Evidence map›Paper›PMID 39658783›Full record

ArticleInfectious diseases of poverty2024

Prevalence and attributable health burdens of vector-borne parasitic infectious diseases of poverty, 1990-2021: findings from the Global Burden of Disease Study 2021.

Yin-Shan Zhu, Zhi-Shan Sun, Jin-Xin Zheng, Shun-Xian Zhang, Jing-Xian Yin, Han-Qing Zhao, Hai-Mo Shen, Gad Baneth, Jun-Hu Chen, Kokouvi Kassegne

Abstract read
In one paragraph

Article in Infectious diseases of poverty, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. [Analysis and Projection of the Burden of Chronic Respiratory Diseases Attributable to Smoking in China, 1990-2021].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Plants (Basel, Switzerland) · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yin-Shan ZhuSchool of Global Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Zhi-Shan SunSchool of Global Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Jin-Xin ZhengSchool of Global Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Shun-Xian ZhangLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Jing-Xian YinSchool of Global Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Han-Qing ZhaoSchool of Global Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Hai-Mo ShenNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), National Health Commission of the People's Republic of China (NHC) Key Laboratory of Parasite and Vector Biology, World Health Organization (WHO) Collaborating Center for Tropical Diseases, National Center for International Research On Tropical Diseases, Shanghai, 200025, China.
Gad BanethKoret School of Veterinary Medicine, The Hebrew University of Jerusalem, Rehovot, Israel.
Jun-Hu ChenNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), National Health Commission of the People's Republic of China (NHC) Key Laboratory of Parasite and Vector Biology, World Health Organization (WHO) Collaborating Center for Tropical Diseases, National Center for International Research On Tropical Diseases, Shanghai, 200025, China. chenjh@nipd.chinacdc.cn.
Kokouvi KassegneSchool of Global Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. ephremk@hotmail.fr.ORCID http://orcid.org/0000-0002-7067-177X

Funding

Science and Technology Commission of Shanghai Municipality 21410750200
6 · The paper itself

Abstract

backgroundVector-borne parasitic infectious diseases associated with poverty (referred to as vb-pIDP), such as malaria, leishmaniasis, lymphatic filariasis, African trypanosomiasis, Chagas disease, and onchocerciasis, are highly prevalent in many regions around the world. This study aims to characterize the recent burdens of and changes in these vb-pIDP globally and provide a comprehensive and up-to-date analysis of geographical and temporal trends.

methodsData on the prevalence and disability-adjusted life years (DALYs) of the vb-pIDP were retrieved from the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2021 for 21 geographical regions and 204 countries worldwide, from 1990-2021. The age-standardized prevalence rate and DALYs rate by age, sex, and sociodemographic index (SDI) were calculated to quantify temporal trends. Correlation analysis was performed to examine the relationship between the age-standardized rate and the SDI.

resultsOver the past 30 years, the age-standardized prevalence rate and DALYs rate of these vb-pIDP have generally decreased, with some fluctuations. The distribution of vb-pIDP globally is highly distinctive. Except for Chagas disease, the age-standardized prevalence rate and DALYs rate of other vb-pIDP were highest in low-SDI regions by 2021. Malaria had the highest age-standardized prevalence rate (2336.8 per 100,000 population, 95% UI: 2122.9, 2612.2 per 100,000 population) and age-standardized DALYs rate (806.0 per 100,000 population, 95% UI: 318.9, 1570.2 per 100,000 population) among these six vb-pIDP globally. Moreover, significant declines in the age-standardized prevalence rate and DALYs rate have been observed in association with an increase in the SDI . Globally, 0.14% of DALYs related to malaria are attributed to child underweight, and 0.08% of DALYs related to malaria are attributed to child stunting.

conclusionsThe age-standardized prevalence rate and DALY rates for the vb-pIDP showed pronounced decreasing trends from 1990-2021. However, the vb-pIDP burden remains a substantial challenge for vector-borne infectious disease control globally and requires effective control strategies and healthcare systems. The findings provide scientific evidence for designing targeted health interventions and contribute to improving the prevention and control of infectious diseases.

Indexed as

Disability-Adjusted Life YearsGlobal Burden of DiseasePovertyAdolescentAdultAgedChildChild, PreschoolFemaleGlobal HealthHumansInfantInfant, NewbornMaleMiddle AgedParasitic DiseasesAfrican trypanosomiasisChagas diseaseGlobal burden of diseaseLeishmaniasisLymphatic filariasisMalariaOnchocerciasisSociodemographic index

Identifiers

PMID39658783
PMCPMC11633012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.